Hospitals & Providers

Transplant eligibility issues and drug regimen options raise difficult questions when treating older multiple myeloma patients.

Gender bias in patient care has damaging effects, especially for women.

A new study led by UCLA researchers has eye-opening findings about low-cost, high-volume unnecessary healthcare. These low-value services may surprise you.

A new study has shocking findings about death rates in heart failure patients enrolled in the Hospital Readmissions Reduction Program.

CAR T-cell therapies and other immunotherapy give this oncologist’s cancer patients hope for a better quality of life.

Plans must be able to deploy these five tactics, whether using internal resources or collaborating with a vendor.

Allergist Bradley Chipps, MD, shares research on how to fine-tune asthma management strategies.

A Canadian study reveals how clinicians may be able to identify whether asthma will develop in patients as young as age one.

New healthcare fraud schemes are emerging. Here are a few of the most noteworthy.

Researchers share surprising findings about PCT-guided therapy in antibiotic management in patients with respiratory infections.

While these types of programs have been in place for several years, it can be difficult to gauge who is using them and how, and whether they are achieving their intended goal.

Fluctuations in drug pricing and medication shortages are among the reasons for rising drug prices. Learn how you can protect your hospital’s bottom line.

CVS Health’s Troyen A. Brennan, MD, MPH, brings attention to a unique specialty pharmacy model and value-based contracting.

If your organization is managing a risk-based contract, you are likely working hard to engage physicians. But are you modifying those efforts based on whether physicians are independent or employed? Here’s why you should.

Managing the care for members with cancer is unlike managing care for other chronic diseases. Here’s five ways to better care for cancer patients.

Experts say a cancer care revolution is here. Here’s a closer look at some advancements in cancer treatments to watch.

A new survey on genetic testing has surprisingly results on consumer acceptance and impact for healthcare executives.

A new survey from consumer health companies has revealing findings about American health and well-being.

A Kaiser Permanente study found that a new way to test for HPV has the potential to increase efficiency and decrease waste.

Here are four ways CMS’ final rule related to the 340B Drug Pricing Program could affect the healthcare industry.

The Trump Administration issued two rules rolling back the federal requirement that employers include birth control coverage in their group health plans. Here’s what you need to know.

Albert A. Rizzo, MD, senior medical advisor for the American Lung Association, says the increasing number of drugs in the pipeline could improve airflow and address the underlying disease process.

Widespread adoption of population-focused nursing practice will likely take place over the next five to 10 years. Here’s how to stay ahead of the curve.

New public opinion survey about opioid use from Prime Therapeutics has surprising results.

Unique partnerships between payers and providers focus on keeping patients out of the hospital and on the road to remission.

Just as cancer takes many forms, so does genetic testing. Here’s what you need to know.

Moffitt Cancer Center expert shares her thinking on managing chemotherapy-related side effects.

Education is a significant element of comprehensive care for COPD patients. In this Q&A, one expert shares her recommendations.

The CVS Health-Aetna potential merger will have healthcare executives rethinking traditional industry competitors. Here’s why.

Healthcare executives identify how the industry could be affected if the Aetna-CVS merger goes through.